Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remimazolam versus propofol for bronchoscopy sedation
ChiCTR2400089389Phase 4Not yet recruiting
- Sponsor
- Fourth Affiliated Hospital of Soochow University
- Start
- Sep 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial in bronchopulmonary diseases comparing Remimazolam group with Propofol group (2 arms). Primary endpoint: Composite of desaturation and hypotension. Planned start Sep 2024; status: not yet recruiting.
02
Drugs
remimazolampropofol
03
Conditions
bronchopulmonary diseases
Beyond the preview
Go deeper on ChiCTR2400089389.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400089389.